Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma

✍ Scribed by Ludwig, H.; Viterbo, L.; Greil, R.; Masszi, T.; Spicka, I.; Shpilberg, O.; Hajek, R.; Dmoszynska, A.; Paiva, B.; Vidriales, M.-B.; Esteves, G.; Stoppa, A. M.; Robinson, D.; Ricci, D.; Cakana, A.; Enny, C.; Feng, H.; van de Velde, H.; Harousseau, J.-L.

• Book ID: 121379731
• Publisher: American Society of Clinical Oncology
• Year: 2013
• Tongue: English
• Weight: 262 KB
• Volume: 31
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2011.39.5137